Metoprolol Succinate ER Interactions
There are 532 drugs known to interact with Metoprolol Succinate ER (metoprolol), along with 19 disease interactions, and 4 alcohol/food interactions. Of the total drug interactions, 28 are major, 466 are moderate, and 38 are minor.
- View all 532 medications that may interact with Metoprolol Succinate ER
- View Metoprolol Succinate ER alcohol/food interactions (4)
- View Metoprolol Succinate ER disease interactions (19)
Most frequently checked interactions
View interaction reports for Metoprolol Succinate ER (metoprolol) and the medicines listed below.
- albuterol
- amlodipine
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- clopidogrel
- Eliquis (apixaban)
- famotidine
- Fish Oil (omega-3 polyunsaturated fatty acids)
- furosemide
- gabapentin
- hydrochlorothiazide
- levothyroxine
- lisinopril
- losartan
- magnesium oxide
- metformin
- omeprazole
- pantoprazole
- potassium chloride
- prednisone
- rosuvastatin
- simvastatin
- spironolactone
- tamsulosin
- tramadol
- trazodone
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Metoprolol Succinate ER alcohol/food interactions
There are 4 alcohol/food interactions with Metoprolol Succinate ER (metoprolol).
Metoprolol Succinate ER disease interactions
There are 19 disease interactions with Metoprolol Succinate ER (metoprolol) which include:
- bradyarrhythmia/AV block
- cardiogenic shock/hypotension
- CHF
- diabetes
- hemodialysis
- hypersensitivity
- ischemic heart disease
- PVD
- liver disease
- cerebrovascular insufficiency
- glaucoma
- hyperlipidemia
- hyperthyroidism
- hyperthyroidism PKs
- myasthenia gravis
- pheochromocytoma
- psoriasis
- tachycardia
- asthma/COPD
More about Metoprolol Succinate ER (metoprolol)
- Compare alternatives
- Pricing & coupons
- Reviews (95)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.